Director · Arcutis Biotherapeutics, Inc. · Arcutis Biotherapeutics, Inc. — Stock Option (right to buy)
Side
M
Value
—
Shares
18.1K
Price
—
Executed
Nov 24, 2025
Disclosed
Nov 25, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 24 executedNov 25, 2025 disclosed
ARQT · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Arcutis Biotherapeutics, Inc. — Stock Option (right to buy)
Ticker
ARQT
Shares
18.1K
Price per share
$0
Execution date (reported)
Nov 24, 2025
Owned after transaction
9,000 shares
Days from execution to publication
1
What this establishes
Lin Sue-Jean filed this Form 4 reporting a option exercise of ARQT on Nov 24, 2025. It became public on Nov 25, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Lin Sue-Jeancik:0001867788
Issuer
Arcutis Biotherapeutics, Inc.cik:0001787306
Revision history · 0
No field has changed since this record was first ingested.
